Scott Bizily - Mar 1, 2023 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Signature
/s/ August J. Moretti, Attorney-in-Fact for Scott Bizily
Stock symbol
FDMT
Transactions as of
Mar 1, 2023
Transactions value $
-$31,218
Form type
4
Date filed
3/3/2023, 05:16 PM
Previous filing
Feb 14, 2023
Next filing
Apr 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FDMT Common Stock Options Exercise $12.2K +1.88K +75.54% $6.49 4.36K Mar 1, 2023 Direct F1
transaction FDMT Common Stock Sale -$43.4K -2.25K -51.6% $19.30 2.11K Mar 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Options Exercise $0 -1.88K -8.47% $0.00 20.3K Mar 1, 2023 Common Stock 1.88K $6.49 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of June 16, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.